NYMOX PHARMACEUTICAL CORP — All Filings
402 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
20-F
20-F/A
20FR12G
20FR12G/A
25-NSE
3
4
4/A
424B3
424B5
6-K
6-K/A
CORRESP
CT ORDER
EFFECT
F-1
F-1/A
F-3
F-3/A
NT 20-F
POS AM
SC 13D
SC 13G
SC 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 20-F | FORM 20-F | 0001640334-22-000622 | Mar 30, 2022 | Dec 31, 2021 |
| F-3 | F-3 | 0001640334-22-000599 | Mar 29, 2022 | — |
| 6-K | FROM 6-K | 0001640334-22-000558 | Mar 22, 2022 | — |
| 424B5 | 424B5 | 0001640334-22-000556 | Mar 22, 2022 | — |
| EFFECT | — | 9999999995-22-000267 | Jan 28, 2022 | — |
| CORRESP | — | 0001640334-22-000180 | Jan 25, 2022 | — |
| UPLOAD | — | 0000000000-21-015284 | Dec 22, 2021 | — |
| F-3 | FORM F-3 | 0001640334-21-003105 | Dec 9, 2021 | — |
| 6-K/A | FORM 6-K-A | 0001640334-21-002938 | Nov 22, 2021 | Nov 19, 2021 |
| 6-K | FORM 6-K | 0001640334-21-002927 | Nov 19, 2021 | — |
| 6-K | FORM 6-K | 0001640334-21-002755 | Nov 12, 2021 | Sep 30, 2021 |
| 6-K | FORM 6-K | 0001640334-21-001859 | Aug 13, 2021 | Jun 30, 2021 |
| 20-F/A | 20-F/A | 0001640334-21-001335 | Jun 11, 2021 | Dec 31, 2020 |
| EFFECT | — | 9999999995-21-002045 | May 20, 2021 | — |
| CORRESP | — | 0001640334-21-001165 | May 17, 2021 | — |
| UPLOAD | — | 0000000000-21-006167 | May 14, 2021 | — |
| 6-K | FORM 6-K | 0001640334-21-001149 | May 14, 2021 | Mar 31, 2021 |
| F-3 | FORM F-3 | 0001640334-21-001119 | May 12, 2021 | — |
| 6-K | FORM 6-K | 0001640334-21-001097 | May 6, 2021 | Apr 30, 2021 |
| 4 | PRIMARY DOCUMENT | 0001651844-21-000001 | Apr 27, 2021 | Apr 21, 2021 |
| 20-F | FORM 20-F | 0001640334-21-000680 | Mar 29, 2021 | Dec 31, 2020 |
| 6-K | FORM 6-K | 0001640334-20-002907 | Nov 20, 2020 | Nov 19, 2020 |
| 6-K | FORM 6-K | 0001640334-20-002891 | Nov 19, 2020 | Nov 18, 2020 |
| 6-K | FORM 6-K | 0001640334-20-002804 | Nov 13, 2020 | Sep 30, 2020 |
| 6-K | FORM 6-K | 0001640334-20-002547 | Oct 13, 2020 | — |
| 6-K | FORM 6-K | 0001640334-20-002150 | Aug 14, 2020 | Jun 30, 2020 |
| 6-K | FORM 6-K | 0001640334-20-002151 | Aug 14, 2020 | — |
| 424B5 | 424B5 | 0001640334-20-002102 | Aug 14, 2020 | — |
| 424B5 | 424B5 | 0001640334-20-002108 | Aug 14, 2020 | — |
| 6-K | FORM 6-K | 0001640334-20-002060 | Aug 13, 2020 | Aug 11, 2020 |
| 6-K | FORM 6-K | 0001640334-20-002040 | Aug 12, 2020 | — |
| 6-K | FORM 6-K | 0001640334-20-001817 | Jul 20, 2020 | Jul 17, 2020 |
| 424B5 | 424B5 | 0001640334-20-001812 | Jul 17, 2020 | — |
| 6-K | FORM 6-K | 0001640334-20-001197 | May 14, 2020 | Mar 31, 2020 |
| EFFECT | — | 9999999995-20-001125 | May 12, 2020 | — |
| CORRESP | — | 0001640334-20-001113 | May 7, 2020 | — |
| F-3/A | F-3/A | 0001640334-20-001052 | May 6, 2020 | — |
| F-3/A | FORM F-3/A | 0001640334-20-000917 | Apr 24, 2020 | — |
| 6-K | FORM 6-K | 0001640334-20-000907 | Apr 24, 2020 | Apr 23, 2020 |
| UPLOAD | — | 0000000000-20-003129 | Apr 10, 2020 | — |
| F-3 | FORM F-3 | 0001640334-20-000720 | Apr 3, 2020 | — |
| 20-F | FORM 20-F | 0001640334-20-000668 | Mar 30, 2020 | Dec 31, 2019 |
| 6-K | REPORT OF FOREIGN ISSUER FOR THE PERIOD ENDED NOVEMBER 19, 2019 | 0001176256-19-000342 | Nov 19, 2019 | — |
| 6-K | FORM 6-K | 0001640334-19-002273 | Nov 13, 2019 | Sep 30, 2019 |
| 6-K | FORM 6-K | 0001640334-19-001644 | Aug 14, 2019 | Jun 30, 2019 |
| 4 | PRIMARY DOCUMENT | 0001651844-19-000023 | Jul 12, 2019 | Jul 10, 2019 |
| 4 | PRIMARY DOCUMENT | 0001651844-19-000022 | Jul 10, 2019 | — |
| 4 | PRIMARY DOCUMENT | 0001651844-19-000021 | Jul 9, 2019 | Jul 5, 2019 |
| 4 | PRIMARY DOCUMENT | 0001651844-19-000020 | Jul 3, 2019 | Jul 2, 2019 |
| 4 | PRIMARY DOCUMENT | 0001651844-19-000019 | Jul 2, 2019 | Jul 1, 2019 |